Study on Airflow Limitation in COPD and Emphysema

Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap

Recruiting Observational Study
COPD, Emphysema, Asthma COPD Overlap Emphysema
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
30 and older
Sex
Any
Study type
Observational
Participants needed
60 (estimated)
Sponsor
Gelb, Arthur F., M.D. · Individual
Who this trial is looking for

This trial is looking for current or former smokers with COPD, emphysema, and asthma-COPD overlap. Participants will help researchers understand why some people have trouble exhaling air.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have asthma-COPD overlap
  • I have emphysema and a smoking history of more than 15 pack years
  • I have COPD or bronchitis and a smoking history of more than 15 pack years

You may not be able to join if

  • I am a non-smoker
  • I have another pulmonary diagnosis
  • I have pulmonary fibrosis

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The purpose of this cross-sectional, observational study is to evaluate the site and mechanism(s) for expiratory airflow limitation in chronic, treated, current or former smokers (\>15 pack years) with COPD, Emphysema, and Asthma-COPD Overlap with mild to severe expiratory airflow limitation. Treatment may include short and long acting inhaled beta2agonists, short and long acting inhaled muscarini…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * asthma- copd overlap * emphysema in smokers with smoking history \> 15 pack years * COPD/ bronchitis and bronchiectasis in smokers with smoking history * \>15 pack years Exclusion Criteria:other pulmonary or systemic diagnosis * non smokers * any other pulmonary diagnosis * …
Contacts

Arthur F Gelb, MD

562-633-2204

afgelb@msn.com

CONTACT

Christine Fraser

562-633-2204

familyfrase@msn.com

CONTACT